Related Experiment Video

Updated: May 23, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Expression and role of HMGA1 in renal cell carcinoma

Natsuki Takaha1, Yoshihiro Sowa, Ichiro Takeuchi

  • 1Department of Translational Cancer Drug Development, Kyoto Prefectural University of Medicine, Kyoto, Japan. ntakaha@koto.kpu-m.ac.jp

The Journal of Urology
|April 17, 2012
PubMed
Abstract

Insights

High mobility group AT-hook 1 (HMGA1) is overexpressed in metastatic renal cell carcinoma (mRCC). Targeting HMGA1 may offer new therapeutic strategies for mRCC patients, as its suppression inhibits tumor growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastatic renal cell carcinoma (mRCC) treatment remains challenging, with limited complete responses and side effects from current therapies.
  • Novel molecular targets are crucial for improving mRCC outcomes.
  • High mobility group AT-hook 1 (HMGA1) is implicated in cancer progression and metastasis, with low expression in normal tissues.

Purpose of the Study:

  • To investigate the expression and functional role of HMGA1 in human renal cell carcinoma (RCC).
  • To evaluate HMGA1 as a potential therapeutic target for metastatic RCC.

Main Methods:

  • HMGA1 expression was analyzed in RCC surgical specimens and cell lines using immunoblot and immunofluorescence.
  • siRNA-mediated knockdown of HMGA1 was performed in ACHN and Caki-1 cell lines.
  • Functional assays assessed the impact of HMGA1 knockdown on colony formation, apoptosis, invasion, migration, and anoikis.

Main Results:

  • HMGA1 was significantly overexpressed in metastatic RCC tumor tissues compared to normal kidney tissue and nonmetastatic RCC.
  • Nuclear HMGA1 expression was confirmed in metastatic RCC cell lines.
  • HMGA1 knockdown suppressed colony formation, induced apoptosis, inhibited invasion and migration, and promoted anoikis, associated with P-Akt down-regulation.

Conclusions:

  • HMGA1 is frequently expressed in metastatic RCC and plays a significant role in tumor progression.
  • HMGA1 represents a promising molecular target for developing novel therapeutic strategies for metastatic renal cell carcinoma.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...